Richard Morris
Director of Finance/CFO presso CARISMA THERAPEUTICS, INC.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Richard Steven Morris is currently the Chief Financial Officer at CTx Operations, Inc. and Carisma Therapeutics, Inc. He previously held positions as the VP-Financial Planning & Strategic Analysis at Shire ViroPharma, Inc. from 2012 to 2014, the Chief Financial Officer at Vitae Pharmaceuticals LLC from 2014 to 2016, the Chief Financial Officer at Passage Bio, Inc. from 2019 to 2021, and the Chief Financial Officer & Executive Vice President at Context Therapeutics LLC from 2017 to 2019.
He obtained his undergraduate degree from St. Joseph's University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 31/01/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Richard Morris
| Società | Posizione | Inizio |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Director of Finance/CFO | 01/06/2021 |
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Director of Finance/CFO | 01/06/2021 |
Precedenti posizioni note di Richard Morris
| Società | Posizione | Fine |
|---|---|---|
| PASSAGE BIO, INC. | Director of Finance/CFO | 30/05/2021 |
Context Therapeutics LLC
 Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | Director of Finance/CFO | 01/07/2019 |
| VITAE PHARMACEUTICALS INC | Director of Finance/CFO | 25/10/2016 |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Comptroller/Controller/Auditor | 25/06/2012 |
Formazione di Richard Morris
| St. Joseph's University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PASSAGE BIO, INC. | Health Technology |
| CARISMA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Health Technology |
Vitae Pharmaceuticals LLC
 Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vitae Pharmaceuticals LLC is a clinical-stage bio-pharmaceutical company, which engages in discovering and developing novel, small molecule drugs for diseases, including chronic kidney disease, diabetes and Alzheimer's disease, and autoimmune disorders, acute coronary syndrome, and immuno-oncology. The company was founded by John J. Baldwin, Bartosz A. Grzybowski, George M. Whitesides, and Eugene Shakhnovich on May 21, 2001 and is headquartered in Fort Washington, PA. | Health Technology |
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Health Technology |
Context Therapeutics LLC
Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | Health Technology |
- Borsa valori
- Insiders
- Richard Morris
